Mulugeta Tarekegn Angamo (M T Angamo, Mulugeta T Angamo)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 4

Top Topics

Extracorporeal Membrane Oxygenation

Mycobacterium Tuberculosis

Top Venues

Journal of clinical pharmacy and therapeutics

Drug, healthcare and patient safety

Jimma University College of Public Health and Medical Sciences

University of Tasmania (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Jimma University College of Public Health and Medical Sciences

Ethiopia

Lecturer, Clinical pharmacist and Researcher :: Pharmacy

University of Tasmania

Australia

Academic Tutor :: School of Pharmacy and Pharmacology

Education History

University of Tasmania

Australia

PHD :: Pharmacy

Publications

Mulugeta Tarekegn Angamo, Mohammed A Mohammed, Gregory M Peterson
Efficacy and safety of remdesivir in hospitalised COVID-19 patients: a systematic review and meta-analysis. Infection (2021)
Teklehaimanot Fentie Wendie, Mulugeta Tarekegn Angamo
Drug-Therapy Problems and Predictors among Hospitalized Heart-Failure Patients: A Prospective Observational Study. Drug, healthcare and patient safety 12 (2020)
Mulugeta Tarekegn Angamo, L Chalmers, C M Curtain, D Yilma, L Bereznicki
Mortality from adverse drug reaction-related hospitalizations in south-west Ethiopia: A cross-sectional study. Journal of clinical pharmacy and therapeutics 43 (6) (2018)
Mulugeta Tarekegn Angamo, Colin Michael Curtain, Leanne Chalmers, Daniel Yilma, Luke Bereznicki
Predictors of adverse drug reaction-related hospitalisation in Southwest Ethiopia: A prospective cross-sectional study. PloS one 12 (10) (2017)